Close Menu

NEW YORK – T2 Biosystems said on Tuesday that its third quarter revenues fell 36 percent year over year, driven by a reduction in research revenues.

For the three months ended Sept. 30, the company reported revenues of $1.6 million compared to $2.5 million in the prior-year period, short of analysts' consensus estimate of $2.0 million.

Q3 product revenues rose 17 percent year over year to $1.4 million from $1.2 million, and research revenues dropped 83 percent to $200,000 from $1.2 million in Q3 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.